Related references
Note: Only part of the references are listed.MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Role of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazide
Chan-Ju Wang et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2010)
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954
G. A. Prosser et al.
BIOCHEMICAL PHARMACOLOGY (2010)
xia2: an expert system for macromolecular crystallography data reduction
G. Winter
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2010)
A Novel Mechanism for Azoreduction
Ali Ryan et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases
Ali Ryan et al.
PROTEIN & CELL (2010)
Site-directed mutagenesis of substrate binding sites of azoreductase from Rhodobacter sphaeroides
Guangfei Liu et al.
BIOTECHNOLOGY LETTERS (2008)
Molecular cloning, characterisation and ligand-bound structure of an azoreductase from Pseudomonas aeruginosa
Chan-Ju Wang et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Nitrofurans as novel anti-tuberculosis agents: Identification, development and evaluation
Rajendra P. Tangallapally et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Bioactivation and hepatotoxicity of nitroaromatic drugs
Urs A. Boelsterli et al.
CURRENT DRUG METABOLISM (2006)
Optimal description of a protein structure in terms of multiple groups undergoing TLS motion
J Painter et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954
Y Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone -: Reversed binding orientations in different redox states of the enzyme
PR Race et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Crystal structure and functional characterization of yeast YLR011wp, an enzyme with NAD(P)H-FMN and ferric iron reductase activities
D Liger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mechanism of carcinogenesis induced by a veterinary antimicrobial drug, nitrofurazone, via oxidative DNA damage and cell proliferation
Y Hiraku et al.
CANCER LETTERS (2004)
Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form
E Johansson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Structures of nitroreductase in three states - Effects of inhibitor binding and reduction
CA Haynes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Putative ACP phosphodiesterase gene (acpD) encodes an azoreductase
M Nakanishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
